Eiger BioPharma (EIGR) PT Raised to $27 at Citi
Tweet
Share
E-mailGet Alerts EIGR Hot Sheet
Price: $1.73 --0%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on Eiger BioPharma (NASDAQ: EIGR) to $27.00 (from $26.00) while maintaining a Buy rating.
You May Also Be Interested In
- Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson Following Q2 Results
- RCM Technologies (RCMT) PT Raised to $45 at B.Riley
- Semiconductor Manufacturing International Corp. (981:HK) (SMI) PT Raised to HK$153 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
